id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-0914-0001,FDA,FDA-2021-N-0914,Medical Devices; Cardiovascular Devices; Classification of the Electrocardiograph Software for Over-the-Counter Use,Rule,Final Rule,2022-01-18T05:00:00Z,2022,1,2022-01-18T05:00:00Z,,2022-01-18T14:23:14Z,2022-00827,0,0,0900006484f23780